Mitchell S V Elkind Selected Research

Cerebrovascular Disorders (Cerebrovascular Occlusion)

1/2022	Association of Carotid Plaque Morphology and Glycemic and Lipid Parameters in the Northern Manhattan Study.
9/2020	Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers.
1/2019	Pathological correlates of brain arterial calcifications.
1/2018	Association Between Carotid Artery Function and Structure in the Northern Manhattan Study.
1/2018	Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling.
11/2016	Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease.
4/2016	Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke.
11/2015	Lipids and Cerebrovascular Disease: Research and Practice.
9/2015	Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.
1/2014	Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell S V Elkind Research Topics

Disease

115	Stroke (Strokes) 01/2022 - 11/2002
57	Ischemic Stroke 01/2022 - 01/2003
21	Hypertension (High Blood Pressure) 10/2021 - 11/2002
20	Atherosclerosis 06/2022 - 11/2002
18	Inflammation (Inflammations) 11/2019 - 05/2005
13	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 12/2009
13	Atrial Fibrillation 10/2021 - 03/2004
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2005
11	Infections 10/2021 - 12/2014
11	Myocardial Infarction 01/2021 - 05/2006
11	Noma (Nomas) 01/2020 - 06/2008
10	Infarction (Infarctions) 05/2019 - 08/2008
10	Vascular Diseases (Vascular Disease) 11/2017 - 05/2005
9	Heart Diseases (Heart Disease) 01/2022 - 01/2006
9	Diabetes Mellitus 01/2018 - 03/2006
8	Pathologic Constriction (Stenosis) 01/2022 - 05/2009
8	Heart Failure 10/2021 - 03/2013
7	Neoplasms (Cancer) 01/2022 - 08/2013
7	Hemorrhage 01/2021 - 03/2004
7	Cerebral Hemorrhage 01/2021 - 01/2014
7	Lacunar Stroke 03/2016 - 03/2006
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014 - 06/2010
6	Cognitive Dysfunction 01/2022 - 01/2013
5	Dyslipidemias (Dyslipidemia) 01/2022 - 09/2010
5	Transient Ischemic Attack 04/2021 - 01/2003
5	Coronary Disease (Coronary Heart Disease) 06/2019 - 09/2008
5	Hyperlipidemias (Hyperlipidemia) 06/2019 - 11/2002
5	Embolic Stroke 01/2019 - 04/2014
4	Carotid Artery Diseases 09/2020 - 06/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 09/2010
4	Hematoma 01/2020 - 12/2015
4	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 05/2006
3	Obesity 01/2022 - 02/2013
3	Patent Foramen Ovale 10/2021 - 03/2004
3	COVID-19 01/2021 - 01/2020
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 12/2014
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2018 - 09/2011
3	Brain Ischemia (Cerebral Ischemia) 01/2018 - 07/2006
3	Chronic Renal Insufficiency 01/2018 - 05/2014
3	Thrombosis (Thrombus) 10/2014 - 09/2006
3	Insulin Resistance 02/2013 - 10/2010
3	Hypercholesterolemia 01/2013 - 04/2012
2	Dementia (Dementias) 01/2022 - 01/2013
2	Epilepsy (Aura) 01/2021 - 02/2017
2	Non-alcoholic Fatty Liver Disease 09/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2020 - 08/2017
2	Unstable Angina 01/2020 - 01/2019
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

42	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2005
17	LipidsIBA 01/2022 - 05/2004
16	CholesterolIBA 01/2022 - 05/2004
16	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2005
16	C-Reactive ProteinIBA 01/2016 - 05/2006
9	Phenobarbital (Luminal)FDA Link 01/2022 - 08/2015
9	AnticoagulantsIBA 01/2021 - 05/2004
9	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2019 - 10/2006
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2008
8	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2004
5	Apolipoproteins E (ApoE)IBA 01/2021 - 08/2015
5	ApolipoproteinsIBA 01/2021 - 01/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2006
5	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2018 - 01/2005
5	HDL CholesterolIBA 01/2018 - 03/2005
5	Blood Glucose (Blood Sugar)IBA 01/2014 - 06/2008
5	Oxidoreductases (Dehydrogenase)IBA 08/2012 - 07/2005
4	oxidized low density lipoproteinIBA 01/2022 - 11/2009
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 03/2004
4	TroponinIBA 06/2019 - 01/2018
4	Neuroprotective AgentsIBA 09/2017 - 07/2005
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2017 - 07/2009
4	AdiponectinIBA 08/2013 - 04/2012
4	LDL CholesterolIBA 02/2013 - 03/2005
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2009 - 03/2005
3	HDL LipoproteinsIBA 10/2021 - 03/2006
3	Biological ProductsIBA 01/2021 - 07/2011
3	VaccinesIBA 01/2021 - 10/2015
3	Hormones (Hormone)IBA 01/2020 - 09/2006
3	CreatinineIBA 01/2020 - 11/2009
3	Complement System Proteins (Complement)IBA 01/2020 - 07/2006
3	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 03/2013
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 11/2009
3	Fibroblast Growth Factor-23IBA 04/2016 - 05/2014
3	Phosphates (Orthophosphate)IBA 04/2016 - 05/2014
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2016 - 10/2006
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2015 - 03/2004
3	Warfarin (Coumadin)FDA LinkGeneric 09/2015 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 08/2015 - 12/2009
3	Receptor for Advanced Glycation End ProductsIBA 05/2015 - 05/2011
3	Lovastatin (Mevacor)FDA LinkGeneric 08/2012 - 08/2008
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2010 - 10/2006
2	Thrombin FDA Link 01/2021 - 06/2004
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
2	Cystatin CIBA 01/2020 - 01/2018
2	Natalizumab (Tysabri)FDA Link 01/2020 - 03/2017

Therapy/Procedure

29	Therapeutics 01/2022 - 01/2003
11	Secondary Prevention 10/2021 - 03/2004
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
3	Length of Stay 01/2021 - 08/2010
3	Patient Readmission 01/2019 - 01/2016
2	Induced Heart Arrest (Cardioplegia) 01/2020 - 01/2019